Royalty Pharma amends exchange agreement for internal EPA holdings restructuring

Royalty Pharma plc

Amended Exchange Agreement transfers Holdings C Share from RPI EPA Holdings to RPI EPA Vehicle.
Articles of association of Royalty Pharma Holdings Limited amended and restated.
Restructuring involves equity performance awards (EPA) entity substitution.
No changes to publicly traded Royalty Pharma plc's operations or financials.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.